跳至主要内容
临床试验/NL-OMON41357
NL-OMON41357已完成不适用

European survey of cardiovascular disease prevention and diabetes (EuroAspire) - IV - EuroAspire-IV

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 715 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
715

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - *18 years and < 80
  • - first or recurrent clinical diagnosis or treatments for coronary heart disease (see below) will be retrospectively identified from diagnostic registers, hospital discharge lists or other sources
  • - the starting date for identification will be not less than 6 months and not more than 3
  • years prior to the expected date of interview.
  • - Patients may fulfil more than one of the following diagnostic criteria:
  • * Elective or emergency coronary artery by-pass graft (CABG) operation (this includes emergency
  • CABG for AMI).
  • * Elective or emergency percutaneous transluminal coronary angioplasty (PCI) (this includes primary
  • PCI for AMI).
  • * Acute myocardial infarction (ST elevation and Non ST elevation MI)
  • * Acute myocardial ischaemia but no evidence of infarction (Troponin negative)

排除标准

  • Patients admitted to hospital from outside the geographical area

研究者

相似试验